PRLD

Prelude Therapeutics (PRLD)

About Prelude Therapeutics (PRLD)

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

Details

Daily high

$2.06

Daily low

$1.79

Price at open

$1.90

52 Week High

$4.22

52 Week Low

$0.61

Market cap

146.9M

Dividend yield

0.00%

Volume

993,779

Avg. volume

419,468

P/E ratio

-1.20

Prelude Therapeutics News